FDA — authorised 18 June 1959
- Application: NDA011839
- Marketing authorisation holder: PFIZER
- Status: supplemented
FDA authorised Provera on 18 June 1959
Yes. FDA authorised it on 18 June 1959; FDA authorised it on 29 October 1992; FDA authorised it on 17 December 2004.
PFIZER holds the US marketing authorisation.